Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

Clinical trial NCT04778059 · TERMINATED

Trial details

NCT number: NCT04778059
Sponsor: US Biotest, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

2019 Novel Coronavirus Infection COVID-19 Virus Infection SARS Coronavirus 2 Infection SARS-CoV-2 Infection Respiratory Distress Syndrome, Adult Adult Respiratory Distress Syndrome

Start date: 2021-07-27
Primary completion: 2022-05-10
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.